Charles River Laboratories International (CRL) Equity Ratio (2009 - 2025)

Charles River Laboratories International's Equity Ratio history runs 17 years deep, the most recent figure standing at 0.44 for Q4 2025.

• In Q4 2025, Equity Ratio fell 3.38% year-over-year to 0.44; the TTM figure through Dec 2025 stood at 0.44 (down 3.38% YoY), while the FY2025 annual figure was 0.44, down 3.38% from the prior year.
• Equity Ratio was 0.44 for Q4 2025 at Charles River Laboratories International, down from 0.45 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.47 in Q3 2024 to a low of 0.34 in Q3 2021.
• Historically, Equity Ratio has averaged 0.41 across 5 years, with a median of 0.42 in 2023.
• The sharpest annual moves came in 2021 and 2023: Equity Ratio declined 6.3% in 2021, then climbed 22.05% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.36 in 2021, then climbed by 8.48% to 0.39 in 2022, then advanced by 12.11% to 0.44 in 2023, then climbed by 4.6% to 0.46 in 2024, then decreased by 3.38% to 0.44 in 2025.
• The last three Equity Ratio figures came in at 0.44 (Q4 2025), 0.45 (Q3 2025), and 0.44 (Q2 2025), per Business Quant data.